Beneficient (BENF) Q4 2026 earnings summary

Executive summary

• Fiscal 2026 focused on resolving legacy issues, regaining Nasdaq compliance, and strengthening the business foundation.

• Cleared major litigation hurdles, including GWG Holdings, and completed a leadership transition.

• Expanded business lines with new fiduciary financings and launched collateral management services.

Financial highlights

• Investments at fair value declined to $195.5M as of March 31, 2026, from $291.4M a year earlier.

• GAAP revenues for fiscal 2026 were $(39.1)M, down from $(7.9)M in 2025; adjusted revenues were $(48.6)M, down from $(7.4)M.

• GAAP operating loss for fiscal 2026 was $(166.5)M, compared to $(24.2)M in 2025; adjusted operating loss was $(94.0)M, compared to $(61.6)M.

• Net loss attributable to common shareholders was $(87.4)M for fiscal 2026, versus net income of $51.2M in 2025.

• Cash and cash equivalents stood at $2.5M, with debt of $96.8M as of March 31, 2026.

Outlook and guidance

• Focus on expanding the Primary Commitment Program, growing collateral management services, and commercializing AI technology.

• Management believes the company is positioned to pursue broader opportunities and create long-term value.